STOCK TITAN
  1. Home
  2. News
  3. ATR

AptarGroup, Inc. - $ATR STOCK NEWS

Welcome to our dedicated page for AptarGroup news (Ticker: $ATR), a resource for investors and traders seeking the latest updates and insights on AptarGroup stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AptarGroup's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AptarGroup's position in the market.

News
Aptar Awarded US FDA Contract to Study Opportunities for Low Global Warming Potential Propellants for Metered Dose Inhalers
Rhea-AI Summary
AptarGroup, Inc. (NYSE: ATR) announces a contract with the FDA to study low Global Warming Potential propellant metered dose inhalers, supporting ongoing FDA efforts to provide guidance on the regulatory framework. The contracted work is valued at up to approximately $6 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.25%
Tags
none
-
News
Aptar Named Among Top 15 of the ‘World’s Top Companies for Women 2023’ by Forbes
Rhea-AI Summary
AptarGroup, Inc. has been named a World's Top Companies for Women 2023 by Forbes for the third consecutive year. They are ranked 13 out of 400 companies included on the list, placing them in the top 5%. The evaluation was based on employer brand, public opinion, and leadership.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.53%
Tags
none
-
News
Aptar Reports Third Quarter 2023 Results
Rhea-AI Summary
AptarGroup reports strong Q3 performance with 7% sales growth and 55% increase in net income. Core sales increased by 2%. Aptar Pharma and Aptar Beauty segments drove growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.87%
Tags
earnings
News
Aptar Named Among the 100 Best Corporate Citizens for Third Consecutive Year
Rhea-AI Summary
AptarGroup named to 3BL Media's 100 Best Corporate Citizens list for the third consecutive year
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.83%
Tags
none
-
News
Aptar Declares Quarterly Dividend
Rhea-AI Summary
AptarGroup, Inc. declares quarterly cash dividend of $0.41 per share
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.44%
Tags
dividends
-
News
Aptar Appoints Global Finance and Operations Veteran Sarah Glickman to its Board of Directors
Rhea-AI Summary
Sarah Glickman joins AptarGroup's Board of Directors, bringing extensive financial and operational experience from companies like Novartis and Bristol-Myers Squibb. Her appointment underscores Aptar's commitment to a diverse board. Glickman aims to contribute to the company's growth and shareholder value.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.91%
Tags
management
News
Aptar Announces 2023 Investor Day
Rhea-AI Summary
AptarGroup to host Investor Day on September 8, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.39%
Tags
none
-
News
Aptar Reports Second Quarter 2023 Results
Rhea-AI Summary
AptarGroup reports strong Q2 2023 results with a 6% increase in sales and a 31% increase in net income. Core sales grew by 4% and adjusted EBITDA increased by 13%. The company also announced an 8% increase in quarterly dividend. Aptar Pharma and Aptar Beauty performed well, while Aptar Closures segment saw a decline in sales. The CEO highlights the success of pharma proprietary drug delivery systems and fragrance dispensing technologies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.89%
Tags
earnings
-
News
Aptar Announces Quarterly Dividend Increase of 7.9%
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.15%
Tags
dividends
News
Aptar Mourns Passing of Ervin J. LeCoque, First CEO and Board Chairman as a Publicly Traded Company
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.69%
Tags
none
Stock ATR logo
AptarGroup, Inc.

NYSE:ATR

ATR Rankings

#816 Ranked by Market Cap
#847 Ranked by Stock Gains
#1766 Ranked by Dividends

ATR Stock Data

9.67B
65.52M
0.51%
91.82%
0.45%
Metal Can Manufacturing
Manufacturing
Link
United States of America
CRYSTAL LAKE

About ATR

aptar is a leading global supplier of a broad range of innovative dispensing systems for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food, and beverage markets. aptar is headquartered in crystal lake, illinois, with manufacturing facilities in north america, europe, asia and south america. for more information, visit www.aptar.com.